The goal of the series is to examine the changing landscape of global health governance in the context of emerging powers, empowered non-governmental actors, and shifting health priorities. A number of questions will be discussed, including: What effect will the growing burden of noncommunicable diseases have on the economic growth of India and China? Can the WHO maintain a central role in global health governance, with competition from other actors (e.g., World Bank, WTO, MNCs,  Gates Foundation) and the proliferation of  new initiatives not housed by WHO (e.g., Global Fund)? How will the emerging powers (e.g., China, India, Brazil) and the rising nonstate actors affect the international community's ability to set priorities and define the upper limits of acceptable action? How does the entrance of health into the realm of "high politics" affect our way of handling  transnational health threats?

Four roundtables will take place throughout the winter and spring in New York and Washington, DC.

This roundtable series is sponsored by the International Institutions and Global Governance program and made possible by the generous support of the Robina Foundation.